Contents
Introduction
Welcome
Agenda
Session
1
Session
2
Session
3
Session
4
Session
5
Attendees
|
-
Characterization of Beryllium-Specific Memory CD4+ T Cells in
Patients with Chronic Beryllium Disease
Andrew P. Fontenot, Scott J. Canavera, Laia Gharavi, Lee
S. Newman, and Brian L. Kotzin
-
HLA-DP-Unrestricted TNF-a
Release in Be-Stimulated
PBMC from Berylliosis Patients
Massimo Amicosante, Floriana Berretta, Alberto Franchi, Paola Rogliani,
Chiara Dotti, Monica Losi, Raed Dweik, and Cesare Saltini
-
Design, Engineering and Production of Human Recombinant
T Cell Receptor Ligands Derived from HLA-DP
Gregory G. Burrows, Roberto Meza-Romero, Jeff Mooney, Justin
W. Chang, Hans Peter Bachinger, and
Jianya Huan
-
A Flow Cytometric Assay for Beryllium Sensitization: Screening
and Mechanistic Applications
A.J. Jabbour, R.A. Ponce, M.T. Rosato, T.J. Kavanagh, L.S. Newman,
T.K. Takaro, and E.M. Faustman
-
Beryllium Stimulates a Local Angiotensin System in Chronic Beryllium
Disease
T. Hendry-Hofer, A.F. Fontenot, E.A. Barker, M. Boguniewicz,
L.S. Newman, and L.A. Maier
-
High Levels of Nitric Oxide (NO) in Exhaled Breath in Patients
with Chronic Beryllium Disease
R.A. Dweik, D. Laskowski, and S.C. Erzurum
-
Nitric Oxide (NO) Attenuation of Interferon Gamma (IFN-Gamma)
Responses in Chronic Beryllium Disease (CBD): Evidence For Mechanisms
Independent of Interleukin (IL)-18
M.J. Thomassen, C. Farver, R.A. Dweik, D. Culver, B.
Yen-Lieberman, M. Kavuru, and B.P. Barna
-
Dosimetry of Beryllium in an Animal Model by Accelerator Mass
Spectrometry
M.L. Chiarappa-Zucca, R.C. Finkel, J.E. McAninch, R.E.
Martinelli and K.W. Turteltaub
-
Identification of Non-Toxic Beryllium-Chelating Porphyrins and
Method of Delivery to Mice in an Attempt to Reduce the Lung Beryllium
(Be) Burden in Chronic Beryllium Disease (CBD)
Jim Klostergaard and George P. Sakalosky
-
Surface Area of Respirable Beryllium Metal, Oxide, and Copper
Alloy Aerosols and Implications for Assessment of Exposure Risk
of Chronic Beryllium Disease
A.B. Stefaniak, M.D. Hoover, R.M. Dickerson, E.J. Peterson,
G.A. Day, P.N. Breysse, M.S. Kent, and R.C. Scripsick
-
Examining Beryllium Chemistry with Modern Analytical Techniques
M. Sutton, S.R. Burastero, C. Mundy, and J. Quong
-
Functional TNF-a
Promoter Polymorphisms Associated
With Chronic Beryllium Disease and Beryllium-Induced
TNF-a
L.A. Maier, R.T. Sawyer, T. Hendry-Hofer, C. Parsons,
R. Bauer, D. McGrath, P. Lympany, R. duBois and L.S. Newman
-
Association of HLA Class II Markers and Beryllium Hypersensitivity
and Disease: Reevaluation of Previously Published Data after 4-8
Years of Follow-up
C. Saltini and M. Rossman
-
Electrostatic Potential on HLA-DP*1701 and HLA-DP*0401: Implications
for Putative Mechanism of Chronic Beryllium Disease
James A. Snyder, Ainsley Weston, Sally T. Tinkle, and Eugene
Demchuk
-
Cutaneous Application of Beryllium Salts and Oxide Particles
Produces Beryllium-Specific Peripheral Sensitization in the C3H/HeOuJ
Mice
Sally Tinkle, James Antonini, Jenny Roberts, Rebecca
Salmen, Karyn Depree, and Melanie Flint
-
In Vitro Transformation of Phagocytized Beryllium Oxide
Particles in the Murine J774A.1 Cell
G.A. Day, A.B. Stefaniak, M.D. Hoover, R.M. Dickerson,
E.J. Peterson, N.A. Esmen, and R.C. Scripsick
-
The Mouse Deep Lung is Exposed to Respirable Particles Administered
by Pharyngeal Aspiration
A.F. Hubbs, G.V.S. Rao, M. Kashon, R. Salmen, L.A. Battelli,
P. Willard, J. Antonini, D.N. Weissman, and S. Tinkle
-
Beryllium-Induced Macrophage Apoptosis in Chronic
Beryllium Disease
R.T. Sawyer, V.A. Fadok, L.A. Maier, L.A. Kittle, J.M.
Routes, and L.S. Newman
Date Published: June 2002
Prepared for the
U.S. Department of Energy
Office of Science
Biological and Environmental Research Program
in cooperation with
National Institute for Occupational Safety and Health
and
National Jewish Medical and Research Center
Prepared by
Human Genome Management Information System
Oak Ridge National Laboratory
Oak Ridge, TN 37830
Managed by
UT‑Battelle, LLC
for the
U.S. DEPARTMENT OF ENERGY
UNDER CONTRACT DE-AC05-00OR22725
|